Issue :

SFDA has issued a recall of two batches of Rozel due to the product is not comply with the requirements of the executive regulations for the Pharmaceutical establishments system.

Recommendations :

For healthcare professionals:

• Stop dispensing the two batches of product immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
• Contact the recalling firm or SFDA if you have any questions about the recall.
• Adverse reactions or quality problems experienced with the use of this two batches may be reported to Saudi Vigilance either online or call center (Call 19999).